The chief counsel of the FDA has been accused of improperly intervening in several lawsuits on the side of pharmaceutical manufacturers by filing friend-of-the-court briefs. The suits include one against Pfizer, whom Daniel Troy once represented, as well as suits against a GlaxoSmithKline unit and makers of medical devices.

Related Summaries